Top Markets
Coin of the day
Heska Corporation Heska Corporation

Heska Corporation

HSKA
Pozycja w akcjach #9993
Heska Corporation provides specialized diagnostic and animal health products,... Heska Corporation provides specialized diagnostic and animal health products, predominantly for canine and feline veterinary care markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. Its product line includes a variety of veterinary chemistry analyzers: the Element DC, DCX, and DC5x series, along with the Element RC, RCX, and RC3X systems, all tailored for blood chemistry and electrolyte analysis. For hematological assessments, Heska offers the Element HT5 and scil Vet abc Plus analyzers, capable of measuring blood cell and platelet counts, as well as hemoglobin levels. The company also supplies Element POC analyzers for blood gas and electrolyte testing, Element i immunodiagnostic analyzers, and the Element COAG and Element AIM veterinary analyzers for coagulation studies. Beyond analytical instruments, Heska's offerings extend to advanced imaging and clinical solutions such as HeskaView Telecytology, which provides automated microscopic slide scanning equipment for clinics, and IV infusion pumps. They also distribute digital radiography hardware, including mobile units, sophisticated ultrasound systems, and Cloudbank, a web-based platform for image storage. For rapid, in-clinic detection, point-of-care products are available to identify antigens and antibodies associated with infectious and parasitic diseases in animals. Therapeutic options include Tri-Heart Plus chewable tablets for treating canine heartworm, ascarid, and hookworm infections. The company also specializes in allergy management, offering ALLERCEPT definitive allergen panels for diagnosis and personalized therapy shots or drops. Furthermore, Heska develops a range of vaccines for bovine health. It supplies biological and pharmaceutical products to other animal health companies and offers comprehensive turnkey services encompassing research, licensing, production, labeling, packaging, validation support, and distribution. Products are distributed to veterinarians via a direct telephone sales force, third-party distributors, trade shows, print advertisements, and other strategic partnerships. Founded in 1988, the company was initially known as Paravax, Inc. before rebranding as Heska Corporation in 1995. Its corporate headquarters are located in Loveland, Colorado.
Cena akcji
$119.99
Ostatnia synchronizacja: 2023-06-12
Kapitalizacja rynkowa
$908.08M
Zmiana (1 dzień)
0.04%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Heska Corporation (HSKA)

Kategoria

Cena HSKA z kapitalizacją rynkową B
Heska Corporation Heska Corporation
HSKA
$119.99
Kapitalizacja rynkowa Heska Corporation(HSKA)
Kapitalizacja rynkowa: $908.08M
Na dzień August 2026 spółka Heska Corporation ma kapitalizację rynkową wynoszącą $908.08M. Według naszych danych, czyni to Heska Corporation 9993rd najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Heska Corporation od 1997 do 2026
HSKA w porównaniu do 5 najpopularniejszych stocks
Cena za HSKA Aktywa B Kapitalizacja rynkowa B Wyniki
Heska Corporation Heska Corporation
$695,543 $908.08M
$5.264T +579,567.27%
Heska Corporation Heska Corporation
$621,205 $908.08M
$4.701T +517,613.57%
Heska Corporation Heska Corporation
$551,953 $908.08M
$4.177T +459,898.87%
Heska Corporation Heska Corporation
$504,413 $908.08M
$3.817T +420,279.57%
Heska Corporation Heska Corporation
$378,744 $908.08M
$2.866T +315,546.54%